Welcome to our dedicated page for Dynatrace SEC filings (Ticker: DT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Dynatrace, Inc. (NYSE: DT) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Dynatrace’s governance, financial reporting practices, and material events related to its AI-powered observability business.
Dynatrace uses Form 8-K current reports to disclose significant developments. Recent examples include 8-K filings that reference press releases announcing quarterly financial results for periods such as the fiscal quarter ended September 30, 2025, and filings that describe amendments to the company’s bylaws. Another 8-K details the results of the annual meeting of stockholders, including director elections, ratification of the independent registered public accounting firm, and the outcome of an advisory vote on executive compensation.
The company’s definitive proxy statement on Schedule 14A provides information about its annual meeting, board nominees, and proposals presented to stockholders. It explains how stockholders can attend and vote, outlines the matters up for consideration, and summarizes recommendations from the Board of Directors.
Through Dynatrace’s earnings-related filings and attached press releases, readers can review metrics such as annual recurring revenue, total revenue, subscription revenue, operating margins, and free cash flow, along with definitions of non-GAAP financial measures and explanations of how the company uses them. These documents also include forward-looking guidance ranges and discussions of factors that may affect future performance.
On Stock Titan, these filings are paired with AI-powered summaries that highlight key points and help explain complex sections, such as non-GAAP reconciliations or bylaw changes. Users can quickly see which forms were filed, when they were submitted, and what topics they cover, while still having direct access to the full text of each document for deeper analysis.
Dynatrace, Inc. director reports RSU vesting and small share sale. A Dynatrace board member exercised 506 time-based restricted stock units into an equal number of common shares on December 4, 2025, increasing directly held stock. The next day, on December 5, 2025, the director sold 253 shares of Dynatrace common stock at $44.24 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 16, 2025.
Following these transactions, the director beneficially owns 1,265 shares of Dynatrace common stock directly, along with 5,568 restricted stock units that convert into shares as they vest. The RSUs were granted on September 4, 2024, with 25% vesting on September 4, 2025 and the remainder vesting in equal quarterly installments through September 4, 2028, conditioned on continued board service.
Dynatrace insider plans a small Rule 144 stock sale. A holder has filed to sell 253 shares of Dynatrace common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $11,192.72 and 301,488,271 shares outstanding. The shares were acquired as restricted stock from the issuer on December 4, 2025, with the sale expected around December 5, 2025.
Over the prior three months, the same seller, Lisa Campbell, sold 1,013 Dynatrace common shares on September 5, 2025 for gross proceeds of $50,417.01. By signing the notice, the seller represents that they do not know of any material adverse, non‑public information about Dynatrace’s current or prospective operations.
Dynatrace, Inc. director reports vesting of restricted stock units
A Dynatrace, Inc. director filed a Form 4 reporting the vesting and settlement of time-based restricted stock units into common stock. On 12/01/2025, 519 RSUs were converted into 519 shares of Dynatrace common stock, increasing the director’s directly held common stock to 8,651 shares. The RSUs were originally granted on September 1, 2023, with 25% vesting on September 1, 2024 and the remaining units vesting in equal quarterly installments through September 1, 2027, subject to continued board service.
After this transaction, the director also continues to hold 3,631 RSUs, each representing a contingent right to receive one share of Dynatrace common stock if future vesting conditions are met.
Dynatrace, Inc.'s chief executive officer and director reported the vesting of restricted stock units and related share movements in company stock. On 11/15/2025, 5,275 RSUs converted into an equal number of shares of common stock, increasing directly held shares. On the same date, 2,679 shares were withheld by Dynatrace at a price of $46.84 per share to cover tax obligations arising from the vesting. After these transactions, the reporting person directly owned 110,721 shares and indirectly held 500 shares through the Anne Marie McConnell Trust dated July 16, 2021. The RSU grant reported was originally made on December 13, 2021 and fully vested on November 15, 2025 under a staged vesting schedule.
Dynatrace, Inc. (DT) reported an insider transaction by its Senior Vice President and Chief Accounting Officer. On 11/17/2025, the executive sold 2,000 shares of Dynatrace common stock at a price of $46.69 per share in an open market transaction coded as a sale. After this trade, the executive beneficially owns 23,380 shares of Dynatrace common stock in direct ownership. The filing notes that this sale was carried out under a prearranged Rule 10b5-1 trading plan adopted on June 5, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Dynatrace, Inc. (DT) reported an insider transaction by its Chief Executive Officer and Director. On 11/11/2025, the reporting person sold 30,000 shares of common stock at a weighted average price of $46.607, with individual sale prices ranging from $46.37 to $46.73, pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025.
Following the sale, the reporting person beneficially owned 108,125 shares directly and 500 shares indirectly through a trust, as described in the footnotes. The filing was made by one reporting person and reflects a standard Form 4 disclosure of insider activity.
Dynatrace, Inc. reported Q2 FY2026 results with total revenue of $493.8 million, up 18% year over year, driven by subscription revenue of $473.1 million. Annual recurring revenue reached $1.899 billion, up 17%.
GAAP income from operations was $73.0 million, and net income was $57.2 million (diluted EPS $0.19). Gross profit was $404.1 million. The company ended the quarter with cash and cash equivalents of $1.225 billion and generated free cash flow of $27.8 million. Remaining performance obligations were $3,038.0 million, with 52% expected to be recognized over the next 12 months.
North America contributed $250.7 million (51%) of revenue; the United States accounted for $223.4 million (45%). Deferred revenue was $889.9 million (current). Under its repurchase program, Dynatrace bought 1.0 million shares for $50.0 million in the quarter, with $232.3 million still available. There was no debt outstanding under the $400.0 million revolving credit facility.
Dynatrace, Inc. furnished an 8-K announcing it issued a press release and will hold a conference call to discuss financial results for the fiscal quarter ended September 30, 2025.
The press release is provided as Exhibit 99.1, and an investor presentation titled “Q2 FY26 Total ARR Expansion Trends” is included as Exhibit 99.2. The information under Item 2.02 is stated as furnished, not filed, under the Exchange Act.
Dynatrace (DT) insider transaction: The company’s SVP and Chief Accounting Officer reported the vesting of 1,322 shares of Common Stock on 10/15/2025 from previously granted RSUs. To cover tax withholding, 517 shares were withheld by the issuer at a price of $47.78 per share. Following these transactions, the reporting person directly owns 25,380 shares.
The RSUs were granted on October 15, 2023; 25% vested on October 15, 2024, with the remainder vesting in equal quarterly installments until fully vested on October 15, 2027, subject to continued employment.
Dynatrace, Inc. (DT) reported an insider sale by Dan Zugelder, Executive Vice President and Chief Revenue Officer. On
The filing shows a pre-arranged sale, not an open-market discretionary trade, because the transaction was effected pursuant to the 10b5-1 plan. No options, derivative transactions, or additional compensation changes are disclosed.
FAQ
What is the current stock price of Dynatrace (DT)?
What is the market cap of Dynatrace (DT)?
